CIK 0001070494
- Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061376651
- Phone
- +1 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 4,450 shares at $20.52 ($91,336)
- 4 Open-market sale Director sold 32,857 shares at $20.03 ($658,234)
- 4 Open-market sale CEO sold 25,000 shares at $17.75 ($443,835)
- 4 Open-market sale Director sold 14,285 shares at $22.54 ($321,925)
- 4 Open-market sale Director sold 30,000 shares at $21.98 ($659,385)
- 4 Open-market sale EXEC VP, CFO AND CBO sold 15,000 shares at $22.48 ($337,260)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 526,316 shares at $28.50 ($15,000,006)
- 4 Open-market sale VP AND GC sold 42,000 shares at $30.28 ($1,271,718)
- 4 Open-market sale CEO sold 25,000 shares at $24.14 ($603,528)
- 4 Open-market sale Director sold 10,000 shares at $24.18 ($241,764)
- 4 Open-market sale CEO sold 25,000 shares at $24.01 ($600,288)
Page 22 of 35 · 686 filings